The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial
- DOI
- 10.1093/oncolo/oyag177
- Published
- 2026-05-08
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyag177,
title = {The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial},
author = {Félix Guerrero-Ramos and Carmen Gómez-Cañizo and Marta Rodríguez-Izquierdo and Mario Hernández-Arroyo and Alfredo Rodríguez-Antolín and Guillermo de Velasco and Santiago Ponce-Aix and Jesús M Paramio and Cristian Suárez-Cabrera and Carolina Rubio and Lucía Morales and Víctor García-Martínez and Marta Dueñas and Daniel Castellano},
year = {2026},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyag177},
url = {https://doi.org/10.1093/oncolo/oyag177}
}RIS
TY - JOUR TI - The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial AU - Félix Guerrero-Ramos AU - Carmen Gómez-Cañizo AU - Marta Rodríguez-Izquierdo AU - Mario Hernández-Arroyo AU - Alfredo Rodríguez-Antolín AU - Guillermo de Velasco AU - Santiago Ponce-Aix AU - Jesús M Paramio AU - Cristian Suárez-Cabrera AU - Carolina Rubio AU - Lucía Morales AU - Víctor García-Martínez AU - Marta Dueñas AU - Daniel Castellano PY - 2026 JO - The Oncologist DO - 10.1093/oncolo/oyag177 UR - https://doi.org/10.1093/oncolo/oyag177 ER -
APA
Guerrero-Ramos, F., Gómez-Cañizo, C., Rodríguez-Izquierdo, M., Hernández-Arroyo, M., Rodríguez-Antolín, A., Velasco, G. D., Ponce-Aix, S., Paramio, J. M., Suárez-Cabrera, C., Rubio, C., Morales, L., García-Martínez, V., Dueñas, M., & Castellano, D. (2026). The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial. The Oncologist. https://doi.org/10.1093/oncolo/oyag177
Source records
- crossref · retrieved 2026-09-27T01:58:52.891Z